Shanghai Pharmaceuticals Holding Co. Ltd. Class ASSE: 601607

Announcement on the Approval of the Marketing Authorization Application for Sitagliptin Fumarate Tablets (SPH3127 Tablets)

· Issued by Shanghai Pharmaceuticals Holding Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on the Approval of the Marketing Authorization Application for Sitagliptin Fumarate Tablets (SPH3127 Tablets)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment